Cargando…
Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options
Ovarian cancer is the leading cause of gynecological cancer death. Improved understanding of the biologic pathways and introduction of poly (ADP-ribose) polymerase inhibitors (PARPi) during the last decade have changed the treatment landscape. This has improved outcomes, but unfortunately half the w...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581945/ https://www.ncbi.nlm.nih.gov/pubmed/37737434 http://dx.doi.org/10.1007/s40265-023-01934-0 |